JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 15, 2004; DOI: 10.1124/jpet.104.068387


0022-3565/04/3111-402-410$20.00
JPET 311:402-410, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.068387v1
311/1/402    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawabata, A.
Right arrow Articles by Saito, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawabata, A.
Right arrow Articles by Saito, N.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Proteinase-Activated Receptor-2-Mediated Relaxation in Mouse Tracheal and Bronchial Smooth Muscle: Signal Transduction Mechanisms and Distinct Agonist Sensitivity

Atsufumi Kawabata, Satoko Kubo, Tsuyoshi Ishiki, Naoyuki Kawao, Fumiko Sekiguchi, Ryotaro Kuroda, Morley D. Hollenberg, Toru Kanke, and Naohiro Saito

Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan (A.K., S.K., T.I., N.K., F.S., R.K.); Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.D.H.); and Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Limited, Tokyo, Japan (T.K., N.S.)

We characterized the tracheal and bronchial relaxation caused by proteinase-activated receptor-2 (PAR-2) activation in ddY mice and/or in wild-type and PAR-2-knockout mice of C57BL/6 background. Ser-Leu-Ile-Gly-Arg-Leu-amide (SLIGRL-NH2) and Thr-Phe-Leu-Leu-Arg-amide, PAR-2- and PAR-1-activating peptides, respectively, caused relaxation in the isolated ddY mouse trachea and main bronchus. The relaxation was abolished by specific inhibitors of cyclooxygenase (COX)-1, COX-2, mitogen-activated protein kinase kinase (MEK), and p38 MAP kinase. The MEK and p38 MAP kinase inhibitors did not affect prostaglandin E2-induced relaxation. Inhibitors of cytosolic Ca2+-dependent phospholipase A2 (PLA), Ca2+-independent PLA2, diacylglycerol lipase, tyrosine kinase, and protein kinase C exhibited no or only minor inhibitory effects on the PAR-mediated relaxation. Trypsin, a PAR-2 activator, and 2-furoyl-Leu-Ile-Gly-Arg-Leu-amide, a potent PAR-2-activating peptide, in addition to SLIGRL-NH2, caused airway relaxation in wild-type C57BL/6 mice, as in ddY mice. In PAR-2-knockout mice, the peptide effects were absent and the potency of trypsin decreased. Desensitization of PAR-2 and/or PAR-1greatly suppressed the relaxant effect of trypsin. The bronchial and tracheal tissues displayed distinct sensitivities toward trypsin and the PAR-2-activating peptides. Our data indicate an involvement of both COX-1 and COX-2, and the MEK-extracellular signal-regulated kinase and p38 MAP kinase signaling pathways in the PAR-2- and PAR-1-triggered relaxation of mouse airway tissue, and substantiate a role for PAR-2 in regulating both the trachea and bronchial responsiveness in the mouse lung.


Received for publication March 12, 2004
Accepted June 15, 2004.

Address correspondence to: Atsufumi Kawabata, Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Japan. E-mail: kawabata{at}phar.kindai.ac.jp




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z.-Y. Wang, P. Wang, and D. E. Bjorling
Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1127 - R1135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Q. van der Merwe, F. Moreau, and W. K. MacNaughton
Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms
Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1258 - G1266.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Q. van der Merwe, C. L. Ohland, C. L. Hirota, and W. K. MacNaughton
Prostaglandin E2 Derived from Cyclooxygenases 1 and 2 Mediates Intestinal Epithelial Ion Transport Stimulated by the Activation of Protease-Activated Receptor 2
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 747 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry
Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Q. van der Merwe, M. D. Hollenberg, and W. K. MacNaughton
EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G441 - G451.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Carrier, I. Brochu, A. J. de Brum-Fernandes, and P. D'Orleans-Juste
The Inducible Nitric-Oxide Synthase Modulates Endothelin-1-Dependent Release of Prostacyclin and Inhibition of Platelet Aggregation ex Vivo in the Mouse
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 972 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. W. Balzary and T. M. Cocks
Lipopolysaccharide Induces Epithelium- and Prostaglandin E2-Dependent Relaxation of Mouse Isolated Trachea through Activation of Cyclooxygenase (COX)-1 and COX-2
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 806 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Kawao, M. Nagataki, K. Nagasawa, S. Kubo, K. Cushing, T. Wada, F. Sekiguchi, S. Ichida, M. D. Hollenberg, W. K. MacNaughton, et al.
Signal Transduction for Proteinase-Activated Receptor-2-Triggered Prostaglandin E2 Formation in Human Lung Epithelial Cells
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 576 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Henry, A. D'Aprile, G. Self, T. Hong, and T. S. Mann
Inhibitors of Prostaglandin Transport and Metabolism Augment Protease-Activated Receptor-2-Mediated Increases in Prostaglandin E2 Levels and Smooth Muscle Relaxation in Mouse Isolated Trachea
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 995 - 1001.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.